I agree that this site is using cookies. You can find further informations here.
X
Aboagye, Jeremy
30  results:
Search for persons X
?
1

The public health impact and cost-effectiveness of the R21/..:

Schmit, Nora ; Topazian, Hillary M ; Natama, H Magloire...
The Lancet Infectious Diseases.  24 (2024)  5 - p. 465-475 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Persistence of the immune response after two doses of ChAdO..:

Voysey, Merryn ; Flaxman, Amy ; Aboagye, Jeremy...
Clinical and Experimental Immunology.  211 (2023)  3 - p. 280-287 , 2023
Link: https://doi.org/10.1093/..
 
?
3

Safety and immunogenicity of varied doses of R21/Matrix-M™ ..:

Sang, Samuel ; Datoo, Mehreen S. ; Otieno, Edward...
Wellcome Open Research.  8 (2023)  - p. 450 , 2023
Link: https://doi.org/10.12688..
 
?
4

Tolerability and immunogenicity of an intranasally-administ..:

Madhavan, Meera ; Ritchie, Adam J. ; Aboagye, Jeremy...
eBioMedicine.  85 (2022)  - p. 104298 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Safety and immunogenicity of ChAdOx1 MERS vaccine candidate..:

Bosaeed, Mohammad ; Balkhy, Hanan H ; Almaziad, Sultan...
The Lancet Microbe.  3 (2022)  1 - p. e11-e20 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Safety and immunogenicity of a simian-adenovirus-vectored r..:

Jenkin, Daniel ; Ritchie, Adam J ; Aboagye, Jeremy...
The Lancet Microbe.  3 (2022)  9 - p. e663-e671 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and immunogenicity of R21/Matrix-M vaccine against..:

Datoo, Mehreen S ; Natama, Hamtandi Magloire ; Somé, Athanase...
The Lancet Infectious Diseases.  22 (2022)  12 - p. 1728-1736 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Safety and Immunogenicity of Adenovirus and Poxvirus Vector..:

Folegatti, Pedro M. ; Flaxman, Amy ; Jenkin, Daniel...
Vaccines.  9 (2021)  3 - p. 262 , 2021
Link: https://doi.org/10.3390/..
 
?
9

Author Correction: T cell and antibody responses induced by..:

Ewer, Katie J. ; Barrett, Jordan R. ; Belij-Rammerstorfer, Sandra...
Nature Medicine.  27 (2021)  6 - p. 1116-1116 , 2021
Link: https://doi.org/10.1038/..
 
?
10

Reactogenicity and immunogenicity after a late second dose ..:

Flaxman, Amy ; Marchevsky, Natalie G ; Jenkin, Daniel...
The Lancet.  398 (2021)  10304 - p. 981-990 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Persistence of the immune response after two doses of ChAdO..:

Voysey, Merryn ; Flaxman, Amy ; Aboagye, Jeremy...
https://eprints.soton.ac.uk/476016/1/uxad013.pdf.  , 2023
Link: https://eprints.soton.ac..
 
?
12

Efficacy and immunogenicity of R21/Matrix-M vaccine against..:

Datoo, Mehreen S ; Natama, Hamtandi Magloire ; Somé, Athanase...
https://researchonline.lshtm.ac.uk/id/eprint/4668728/1/Datoo_etal_2022_Efficacy-and-immunogenicity-of-r21.pdf.  , 2022
Link: https://researchonline.l..
 
?
13

Reactogenicity and immunogenicity after a late second dose ..:

Flaxman, Amy ; Marchevsky, Natalie G ; Jenkin, Daniel...
http://eprints.gla.ac.uk/260578/1/260578.pdf.  , 2021
Link: http://eprints.gla.ac.uk..
 
?
14

Reactogenicity and immunogenicity after a late second dose ..:

Flaxman, Amy ; Marchevsky, Natalie G ; Jenkin, Daniel...
https://discovery.ucl.ac.uk/id/eprint/10144343/1/1-s2.0-S0140673621016998-main.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
15

Reactogenicity and immunogenicity after a late second dose ..:

Flaxman, Amy ; Marchevsky, Natalie G ; Jenkin, Daniel...
https://eprints.soton.ac.uk/453799/1/1_s2.0_S0140673621016998_main.pdf.  , 2021
Link: https://eprints.soton.ac..
 
1-15